Catherine Lawrence

Dr. Catherine Lawrence


Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 August 2016 in Nature Communications
Verified
Journal Article
Open access
PDF file
MDMichael Daniels
Michael Daniels
JRJack Rivers-Auty
Jack Rivers-Auty
TSTom Schilling
Tom Schilling
NSNicholas G. Spencer
Nicholas G. Spencer
WWWilliam Watremez
William Watremez
DBDavid Brough
David Brough
Non-steroidal anti-inflammatory drugs (NSAIDs) inhibit cyclooxygenase-1 (COX-1) and COX-2 enzymes. The NLRP3 inflammasome is a multi-protein complex responsible for the processing of the proinflammatory cytokine interleukin-1β and is implicated in many inflammatory diseases. Here we show that several clinically approved and widely used NSAIDs of the fenamate class are effective and selective inhibitors of the NLRP3 inflammasome via inhibition of the volume-regulated anion channel in macrophages, independently of COX enzymes. Flufenamic acid and mefenamic acid are efficacious in NLRP3-dependent rodent models of inflammation in air pouch and peritoneum. We also show therapeutic effects of fenamates using a model of amyloid beta induced memory loss and a transgenic mouse model of Alzheimer’s disease. These data suggest that fenamate NSAIDs could be repurposed as NLRP3 inflammasome inhibitors and Alzheimer’s disease therapeutics.

1 August 2014 in Neurobiology of Aging
Verified
Journal Article
Open access
EKElysse M. Knight
Elysse M. Knight
IMIsaura Martins
Isaura Martins
SGSarah Gümüsgöz
Sarah Gümüsgöz
SAStuart Allan
Stuart Allan
CLCatherine Lawrence
Catherine Lawrence
Obesity and consumption of a high-fat diet are known to increase the risk of Alzheimer's disease (AD). Diets high in fat also increase disease neuropathology and/or cognitive deficits in AD mouse models. However, the effect of a high-fat diet on both the neuropathology and memory impairments in the triple-transgenic mouse model of AD (3xTgAD) is unknown. Therefore, groups of 2-month-old male 3xTgAD and control (non-Tg) mice were maintained on a high-fat or control diet and memory was assessed at the age of 3-4, 7-8, 11-12, and 15-16 months using a series of behavioral tests. A comparable increase in body weight was observed in non-Tg and 3xTgAD mice after high-fat feeding at all ages tested but a significantly greater increase in epididymal adipose tissue was observed in 3xTgAD mice at the age of 7-8, 11-12, and 15-16 months. A high-fat diet caused memory impairments in non-Tg control mice as early as the age of 3-4 months. In 3xTgAD mice, high-fat consumption led to a reduction in the age of onset and an increase in the extent of memory impairments. Some of these effects of high-fat diet on cognition in non-Tg and 3xTgAD mice were transient, and the age at which cognitive impairment was detected depended on the behavioral test. The effect of high-fat diet on memory in the 3xTgAD mice was independent of changes in AD neuropathology as no significant differences in (plaques, oligomers) or tau neuropathology were observed. An acute increase in microglial activation was seen in high-fat fed 3xTgAD mice at the age of 3-4 months but in non-Tg control mice microglial activation was not observed until the age of 15-16 months. These data indicate therefore that a high-fat diet has rapid and long-lasting negative effects on memory in both control and AD mice that are associated with neuroinflammation, but independent of changes in beta amyloid and tau neuropathology in the AD mice.

21 July 2016 in Journal of Cerebral Blood Flow & Metabolism
Verified
Journal Article
Open access
MHMichael J Haley
Michael J Haley
CLCatherine Lawrence
Catherine Lawrence
Blood–brain barrier breakdown worsens ischaemic damage, but it is unclear how molecules breach the blood–brain barrier in vivo. Using the obese ob/ob mouse as a model of enhanced blood–brain barrier breakdown, we investigated how stroke-induced structural changes to the microvasculature related to blood–brain barrier permeability. Ob/ob mice underwent middle cerebral artery occlusion, followed by 4 or 24 h reperfusion. Blood–brain barrier integrity was assessed using IgG and horseradish peroxidase staining, and blood–brain barrier structure by two-dimensional and three-dimensional electron microscopy. At 4 and 24 h post-stroke, ob/ob mice had increased ischaemic damage and blood–brain barrier breakdown compared to ob/– controls, and vessels from both genotypes showed astrocyte end-foot swelling and increased endothelial vesicles. Ob/ob mice had significantly more endothelial vesicles at 4 h in the striatum, where blood–brain barrier breakdown was most severe. Both stroke and genotype had no effect on tight junction structure visualised by electron microscopy, or protein expression in isolated microvessels. Astrocyte swelling severity did not correlate with tissue outcome, being unaffected by genotype or reperfusion times. However, the rare instances of vessel lumen collapse were always associated with severe astrocyte swelling in two-dimensional and three-dimensional electron microscopy. Endothelial vesicles were therefore the best spatial and temporal indicators of blood–brain barrier breakdown after cerebral ischaemia.

1 July 2000 in Nature Neuroscience
Verified
Journal Article
Closed access
PDF file
CLCatherine Lawrence
Catherine Lawrence
Fulvio CelsiFulvio Celsi
Fulvio Celsi
JBJohn Brennand
John Brennand
SLSimon M. Luckman
Simon M. Luckman

1 March 1998 in European Journal of Neuroscience
Verified
Journal Article
Closed access
PDF file
CLCatherine Lawrence
Catherine Lawrence
SAStuart Allan
Stuart Allan
NRNancy J. Rothwell
Nancy J. Rothwell

20 February 2017 in Brain Pathology
Verified
Journal Article
Closed access
PDF file
CWClaire S. White
Claire S. White
CLCatherine Lawrence
Catherine Lawrence
DBDavid Brough
David Brough
JRJack Rivers‐Auty
Jack Rivers‐Auty